C.E. Unterberg, Towbin

C.E. Unterberg, Towbin was a boutique investment bank and brokerage firm that specialized in the technology and healthcare sectors, with a significant focus on biotechnology and life sciences. Founded in 1932, the firm built a reputation for providing high-quality equity research and investment banking services to emerging growth companies. It played a key role in financing numerous healthcare and biotech firms through initial public offerings, private placements, and M&A advisory. In 2007, the firm was acquired by the British financial services group Collins Stewart for approximately $20 million. Following subsequent mergers, its legacy operations were eventually integrated into Canaccord Genuity.